IP Library Granted Patent US 12,390,639
Granted Patent B2
US 12,390,639 · App. 18/140,297 · Granted Aug 19, 2025

Systems and method for delivering pulsed electric current to living tissue

Inventor: John Crosson (Santa Monica, CA)
Assignee: TRUERELIEF, LLC
A61N1/36021A61N1/36034A61N1/0456
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,390,639
App. No.
18/140,297
Granted
Aug 19, 2025
Kind
B2
Abstract

A patient treatment unit for delivering non-invasive pulsed energy to living tissue with a probe stimulus generator circuit configured to output, as a treatment signal, a sequence of DC electrical pulses at a controlled pulse frequency of about 20 kHz and having a pulse voltage defined by a variable supply voltage of the probe stimulus generator circuit. The unit includes primary and secondary probes for contacting a body, an intensity adjustment circuit configured to control the variable supply voltage, and an electronic timer display configured to display an elapsed time in decimal numbers in minute and second format. An electrical current of the pulses is in a range of 0.1-2 mA while the probes are contacting the body. An operating output voltage across the probes while conducting the treatment signal does not exceed a maximum operating output voltage of 165 VDC while the probes are contacting the body.

Claims (44)

1. A patient treatment unit comprising:

a probe stimulus generator circuit that, while in active operation, generates a treatment signal including a pulse train of direct current (DC) pulses having a pulse frequency, a pulse current from 0.1 milliAmperes (mA) to 8.9 mA for a defined range of load impedance, and a pulse voltage dependent on a variable supply voltage supplied to the probe stimulus generator circuit, the variable supply voltage providing a maximum pulse voltage of about 165 Volts of DC (VDC);

a pair of electrically conducting probes coupled to the probe stimulus generator circuit for conducting the treatment signal through a body of a human or animal patient, as the load impedance, via non-invasive contact with skin of the patient, the pair of electrically conducting probes each comprising a rounded hemispherical probe tip;

an adhesive surface configured to attach the rounded hemispherical probe tip of one of the pair of electrically conducting probes to the skin;

a mode control circuit configured to activate and deactivate a treatment mode of the patient treatment unit in response to operator input, wherein the treatment mode is characterized by the active operation of the probe stimulus generator circuit;

an intensity adjustment circuit configured to control the variable supply voltage to start at a predefined starting voltage for each activation of the treatment mode; and

a visual display unit configured to display an elapsed time of treatment by starting at each activation of the treatment mode and stopping at each corresponding deactivation of the treatment, the elapsed time of treatment being displayed in a minutes and seconds format.

2. The patient treatment unit of claim 1 , wherein the variable supply voltage changes between a predefined starting voltage and a variable treatment voltage, the predefined starting voltage being lower than the variable treatment voltage.

3. The patient treatment unit of claim 2 , further comprising a detent wheel on one of the pair of electrically conducting probes, the detent wheel being rotatable to activate and deactivate the treatment mode.

4. The patient treatment unit of claim 1 , wherein the pair of electrically conducting probes include a primary probe having an operating conductor pressure range between 0.5 lbs/in2 and 150 lbs/in2, the primary probe being configured to contact an area of the body of the human or animal patient at an angle between 45-degrees and 90-degrees.

5. A patient treatment unit for delivering non-invasive pulsed energy to living tissue, the patient treatment unit comprising:

a probe stimulus generator circuit configured to output, as a treatment signal, a sequence of direct current (DC) electrical pulses at a controlled pulse frequency and having a pulse voltage defined by a variable supply voltage of the probe stimulus generator circuit;

a primary conductor having an elongated body and a rounded hemispherical tip that is configured to contact a body of a human or animal, the primary conductor being electrically coupled to the probe stimulus generator circuit so as to receive the DC electrical pulses;

a secondary conductor having a rounded hemispherical probe tip and configured to contact the body and electrically coupled to the probe stimulus generator circuit to complete an electrical circuit with the primary conductor through the body;

an intensity adjustment circuit configured to control the variable supply voltage, including setting the variable supply voltage to a predefined starting voltage upon activation of the probe stimulus generator circuit; and

a first electronic timer display configured to display an elapsed time in a human-understandable form, starting from each activation of the probe stimulus generator circuit and running until a corresponding deactivation of the probe stimulus generator circuit;

wherein

at least one of the primary conductor and the secondary conductor includes a probe tip configured to be adhered to the body.

6. The patient treatment unit of 5, further comprising a second electronic timer display configured to display in a human-understandable form a total accumulated time that the probe stimulus generator circuit has delivered the treatment signal since a first time the probe stimulus generator circuit is activated.

7. The patient treatment unit of claim 5 , wherein the intensity adjustment circuit is further configured to increase the variable supply voltage from the predefined starting voltage to a variable treatment voltage after the activation of the probe stimulus generator circuit.

8. The patient treatment unit of claim 7 , further comprising a primary probe, wherein the primary probe includes the primary conductor and a manual setting for increasing the variable supply voltage to the variable treatment voltage.

9. The patient treatment unit of claim 8 , wherein the manual setting is a detent wheel.

10. The patient treatment unit of claim 9 , wherein the detent wheel has a locked off position in which a measurement mode is engaged.

11. The patient treatment unit of claim 10 , wherein the detent wheel is rotatable towards the rounded tip of the primary probe, away from the locked off position.

12. The patient treatment unit of claim 11 , wherein rotation of the detent wheel away from the locked off position results in disengaging the measurement mode and engaging the treatment mode.

13. The patient treatment unit of claim 11 , wherein the rotation of the detent wheel away from the locked off position increases the electrical current.

14. The patient treatment unit of claim 9 , wherein the detent wheel is the only manual setting on the primary probe.

15. The patient treatment unit of claim 7 , wherein the operating output voltage automatically changes between the predefined starting voltage and the variable treatment voltage.

16. The patient treatment unit of claim 5 , further comprising an exterior casing in which the probe stimulus generator circuit, the intensity adjustment circuit, and the electronic timer display are enclosed.

17. The patient treatment unit of claim 5 , further comprising a pressure sensor in the primary conductor configured to output a pressure applied to the rounded tip, the pressure sensor being configured to measure a pressure at the rounded tip between at least 0.5 lbs/in 2 and 150 lbs/in 2 .

18. The patient treatment unit of claim 5 , wherein the pair of electrically conducting probes include a primary probe having an operating conductor pressure range between 0.5 lbs/in2 and 150 lbs/in2, the primary probe being configured to contact an area of the body of the human or animal patient at an angle between 45-degrees and 90-degrees.

19. A method of treating inflammation or a wound in a patient, the method comprising:

applying a first probe and a second probe to living tissue of a patient in an area where inflammation or a wound is indicated, wherein the first probe is adhered to the tissue of the patient;

causing electrical energy to be delivered through the probes and into the tissue in the form of a treatment signal, the treatment signal including a pulse train of direct current (DC) pulses having

a pulse frequency,

a pulse current from 0.1 milliAmperes (mA) to 8.9 mA for a defined range of load impedance, and

a pulse voltage dependent on a variable supply voltage supplied to the probe stimulus generator circuit, the variable supply voltage providing a maximum pulse voltage of about 165 Volts of DC (VDC);

while maintaining the first probe adhered in place, moving the second probe along the living tissue of the patient in a direction along a body of the patient;

picking up the second probe and moving or applying the second probe to the same or a new location on the patient; and

repeating the picking up and moving or picking up and applying steps one or more times to treat the inflammation or wound on the patient,

wherein the first probe and the second probe each comprise a rounded hemispherical probe tip, and the first probe is configured to be adhered to skin of the patient.

20. The method of claim 19 , further comprising changing the variable supply voltage from a predefined starting voltage to a variable treatment voltage after initial activation of the treatment signal.

21. The method of claim 19 , further comprising manually changing the variable supply voltage between a predefined starting voltage and a variable treatment voltage.

22. The method of claim 19 , further comprising automatically changing the variable supply voltage between a predefined starting voltage and a variable treatment voltage.

Assignments (3)
SECURITY INTEREST Recorded Jun 5, 2026
From: TRUERELIEF, LLC
To: GLS HOLDINGS, LLC
Reel/Frame 074862/0970 →
SECURITY INTEREST Recorded Apr 21, 2026
From: TRUERELIEF, LLC
To: MEDCAP PARTNERS, LLC
Reel/Frame 074431/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2023
From: CROSSON, JOHN
To: TRUERELIEF, LLC
Reel/Frame 063479/0248 →
Continuity (5)
Continuation 17538379 · Nov 30, 2021
Continuation 17033099 · Sep 25, 2020
Continuation PCTUS2020037625 · Jun 12, 2020
Provisional Application 62860678 · Jun 12, 2019
Related Publication 20230256245A1 · Aug 17, 2023
References Cited (161)
US 945564A · Marko · 1910 [cited by applicant]
US 4014346A · Brownlee · 1977 [cited by applicant]
US 4014347A · Halleck · 1977 [cited by applicant]
US 4112923A · Tomecek · 1978 [cited by applicant]
US 4173741A · Kameny · 1979 [cited by applicant]
US 4315503A · Ryaby · 1982 [cited by applicant]
US 4319584A · McCall · 1982 [cited by applicant]
US 4376901A · Pettibone · 1983 [cited by applicant]
US 4455527A · Singer · 1984 [cited by applicant]
US 4714886A · Halpern · 1987 [cited by applicant]
US 4769881A · Pedigo · 1988 [cited by applicant]
US 4926865A · Oman · 1990 [cited by applicant]
US 4977895A · Tannenbaum · 1990 [cited by applicant]
US 5045988A · Gritter · 1991 [cited by applicant]
US 5109847A · Liss · 1992 [cited by applicant]
US 5231354A · Leunbach · 1993 [cited by applicant]
US 5304211A · Israel · 1994 [cited by applicant]
US 5343869A · Pross · 1994 [cited by applicant]
US 5347221A · Rubinson · 1994 [cited by applicant]
US 5505932A · Grinstaff · 1996 [cited by applicant]
US 5517119A · Weinstock · 1996 [cited by applicant]
US 5571149A · Liss · 1996 [cited by applicant]
US 5573552A · Hansjurgens · 1996 [cited by applicant]
US 5584863A · Rauch · 1996 [cited by applicant]
US 5592086A · Weinstock · 1997 [cited by applicant]
US 5645526A · Flower · 1997 [cited by applicant]
US 5674261A · Smith · 1997 [cited by applicant]
US 5723001A · Pilla · 1998 [cited by applicant]
US 5814078A · Zhou · 1998 [cited by applicant]
US 5865746A · Murugesan · 1999 [cited by applicant]
US 5900227A · Janzen · 1999 [cited by applicant]
US 5945564A · Takayanagi · 1999 [cited by applicant]
US 6110106A · MacKinnon · 2000 [cited by applicant]
US 6140346A · Andrulis · 2000 [cited by applicant]
US 6157854A · Haber · 2000 [cited by applicant]
US 6238425B1 · Thiberg · 2001 [cited by applicant]
US 6242919B1 · Zuk · 2001 [cited by applicant]
US 6302900B1 · Riggs · 2001 [cited by applicant]
US 6319682B1 · Hochman · 2001 [cited by applicant]
US 6335625B1 · Bryant · 2002 [cited by applicant]
US 6430430B1 · Gosche · 2002 [cited by applicant]
US 6461375B1 · Baudry · 2002 [cited by applicant]
US 6465507B2 · Tang · 2002 [cited by applicant]
US 6495601B1 · Hochman · 2002 [cited by applicant]
US 6496725B2 · Kamada · 2002 [cited by applicant]
US 6566874B1 · Speier · 2003 [cited by applicant]
US 6573063B2 · Hochman · 2003 [cited by applicant]
US 6594527B2 · Mo · 2003 [cited by applicant]
US 6633779B1 · Schuler · 2003 [cited by applicant]
US 6671540B1 · Hochman · 2003 [cited by applicant]
US 6689806B1 · Tang · 2004 [cited by applicant]
US 6706709B2 · Tang · 2004 [cited by applicant]
US 6751506B2 · Shealy · 2004 [cited by applicant]
US 6766202B2 · Underwood · 2004 [cited by applicant]
US 6775573B2 · Schuler · 2004 [cited by applicant]
US 6776573B2 · Arilla · 2004 [cited by applicant]
US 6836114B2 · Reddy · 2004 [cited by applicant]
US 6845262B2 · Albert · 2005 [cited by applicant]
US 6974415B2 · Cerwin · 2005 [cited by applicant]
US 7002147B1 · Hansknecht · 2006 [cited by applicant]
US 7010356B2 · Jog · 2006 [cited by applicant]
US 7058446B2 · Schuler · 2006 [cited by applicant]
US 7082325B2 · Hashimshony · 2006 [cited by applicant]
US 7092760B2 · Foster · 2006 [cited by applicant]
US 7117034B2 · Kronberg · 2006 [cited by applicant]
US 7150710B2 · Haber · 2006 [cited by applicant]
US 7158004B2 · Ahn · 2007 [cited by applicant]
US 7174213B2 · Pless · 2007 [cited by applicant]
US 7198776B2 · Klaveness · 2007 [cited by applicant]
US 7483734B2 · Colthurst · 2009 [cited by applicant]
US 7574257B2 · Rittman · 2009 [cited by applicant]
US 7603171B2 · Eror · 2009 [cited by applicant]
US 7613517B2 · Goroszeniuk · 2009 [cited by applicant]
US 7801585B1 · Weinstock · 2010 [cited by applicant]
US 7847644B2 · Suzuki · 2010 [cited by applicant]
US 8064988B2 · Weinstock · 2011 [cited by applicant]
US 8108047B2 · Schumann · 2012 [cited by applicant]
US 8326398B2 · Weinstock · 2012 [cited by applicant]
US 8849371B2 · Weinstock · 2014 [cited by applicant]
US 9079029B2 · Weinstock · 2015 [cited by applicant]
US 9149386B2 · Fahey · 2015 [cited by applicant]
US 9238138B2 · Lee · 2016 [cited by applicant]
US 9308363B2 · Goroszeniuk · 2016 [cited by applicant]
US 9550068B2 · Weinstock · 2017 [cited by applicant]
US 9737709B2 · Bachinski · 2017 [cited by applicant]
US 10130805B2 · Schonenberger · 2018 [cited by applicant]
US 10499848B2 · Weinstock · 2019 [cited by applicant]
US 10960207B2 · Wong · 2021 [cited by applicant]
US 11197999B2 · Crosson · 2021 [cited by examiner]
US 11198000B2 · Crosson · 2021 [cited by examiner]
US 11666758B2 · Crosson · 2023 [cited by examiner]
US 20010039375A1 · Lee · 2001 [cited by applicant]
US 20020042427A1 · Tang · 2002 [cited by applicant]
US 20020052369A1 · Tang · 2002 [cited by applicant]
US 20020055092A1 · Hochman · 2002 [cited by applicant]
US 20030083724A1 · Jog · 2003 [cited by applicant]
US 20030130709A1 · D.C. · 2003 [cited by applicant]
US 20040015188A1 · Coulter · 2004 [cited by applicant]
US 20050027333A1 · Lennox · 2005 [cited by applicant]
US 20050033381A1 · Carter · 2005 [cited by applicant]
US 20050158285A1 · Giampapa · 2005 [cited by applicant]
US 20050165459A1 · Coulter · 2005 [cited by applicant]
US 20050177201A1 · Freeman · 2005 [cited by applicant]
US 20050177202A1 · Classen · 2005 [cited by applicant]
US 20050197555A1 · Mouradian · 2005 [cited by applicant]
US 20060052720A1 · Ross · 2006 [cited by applicant]
US 20070060800A1 · Drinan · 2007 [cited by applicant]
US 20070106342A1 · Schumann · 2007 [cited by applicant]
US 20070129759A1 · Colthurst · 2007 [cited by applicant]
US 20070179585A1 · Moretti · 2007 [cited by applicant]
US 20080109049A1 · Schumann · 2008 [cited by applicant]
US 20080183098A1 · Denison · 2008 [cited by applicant]
US 20090149732A1 · Weinstock · 2009 [cited by applicant]
US 20090270952A1 · Weinstock · 2009 [cited by applicant]
US 20100204752A1 · Tremblay · 2010 [cited by applicant]
US 20100324627A1 · Weinstock · 2010 [cited by applicant]
US 20110166622A1 · Crosson · 2011 [cited by applicant]
US 20110301450A1 · Hue · 2011 [cited by applicant]
US 20130172838A1 · Tremblay · 2013 [cited by applicant]
US 20170361095A1 · Mueller · 2017 [cited by applicant]
US 20190008410A1 · Crosson · 2019 [cited by applicant]
US 20190388278A1 · Donda · 2019 [cited by applicant]
US 20200077943A1 · Weinstock · 2020 [cited by applicant]
US 20210008369A1 · Crosson · 2021 [cited by applicant]
US 20220080196A1 · Crosson · 2022 [cited by applicant]
AU 2020200898A1 · 2020 [cited by applicant]
CA 2774272A1 · 2010 [cited by applicant]
DE 2443913A1 · 1976 [cited by applicant]
DE 2443913 · 1976 [cited by applicant]
EP 0662311A1 · 1995 [cited by applicant]
EP 0662311 · 1995 [cited by applicant]
EP 1537893A2 · 2005 [cited by applicant]
EP 1537893 · 2005 [cited by applicant]
GB 02434544A · 2007 [cited by applicant]
JP H10509600A · 1998 [cited by applicant]
JP 2003062034A · 2001 [cited by applicant]
JP 2001187035A · 2003 [cited by applicant]
JP 2004243047A · 2004 [cited by applicant]
JP 2008125694 · 2008 [cited by applicant]
JP 2010534114A · 2010 [cited by applicant]
JP 2013544177 · 2013 [cited by applicant]
WO WO9610440A1 · 1996 [cited by applicant]
WO WO03076009A1 · 2003 [cited by applicant]
WO WO2005118061A1 · 2005 [cited by applicant]
WO WO2007075410A2 · 2007 [cited by applicant]
WO WO2007088348A2 · 2007 [cited by applicant]
WO WO2010031055A1 · 2010 [cited by applicant]
WO WO2011106225A2 · 2011 [cited by applicant]
WO WO2017156340A1 · 2017 [cited by applicant]
WO WO2020252406A1 · 2020 [cited by applicant]
International Search Report and Written Opinion in International Application No. PCT/US2011/061451, mailed Jul. 25, 2012 (10 pages). [cited by applicant]
Notice of Allowance corresponding to Japanese Patent Application No. 2013-542044, Japanese Patent Office, dated May 17, 2016 (2 pages). [cited by applicant]
Peeters, A.M.G., “Single-Rail Handshake Circuits,” Dissertation published by Proefschrift Technische Universiteit Eindhoven, 1996. ISBN 90-74445-28-4 (202 pages). [cited by applicant]
Engstrom, S., “Resonances and Magnetic Field Detection in Biological Systems,” Electricity and Magnetism in Biology and Medicine, pp. 223-226; 1999 (4 pages). [cited by applicant]
Muehsam, D.J. & Pilla, A.A., “The Sensitivity of Cells and Tissues to Exogenous Fields: Dependence Upon Target System Initial State,” Electricity and Magnetism in Biology and Medicine, pp. 405-408; 1999 (4 pages). [cited by applicant]
Pilla, A.A. et al., “A Larmor Precession/Dynamical System Model Allows uT-Range Magnetic Field Effects on Ion Binding in the Presences of Thermal Noise,” Electricity and Magnetism in Biology and Medicine, pp. 395-399; 1… [cited by applicant]
Yasui, M. et al., “Effect of Magnetic Field Exposure on Calcium Channel Currents Using Patch-Clamp Technique,” Electricity and Magnetism in Biology and Medicine, pp. 581-584; 1999 (4 pages). [cited by applicant]
International Search Report and Written Opinion in International Application No. PCT/US2006/043582, mailed Mar. 26, 2007 (13 pages). [cited by applicant]
International Search Report and Written Opinion in International Application No. PCT/US2009/056990, mailed Nov. 2, 2009 (7 pages). [cited by applicant]
International Search Report and Written Opinion in International Application No. PCT/US2011/025162, mailed Oct. 31, 2011 (7 pages). [cited by applicant]
International Search Report and Written Opinion in International Application No. PCT/US2020/037625, mailed Oct. 6, 2020 (14 pages). [cited by applicant]